A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Condition(s):Hidradenitis SuppurativaLast Updated:August 11, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Hidradenitis SuppurativaLast Updated:August 11, 2022Completed
Condition(s):Hidradenitis SuppurativaLast Updated:September 26, 2022Completed
Condition(s):HidradenitisLast Updated:March 5, 2024Recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:September 26, 2022Completed
Condition(s):Hidradenitis SuppurativaLast Updated:February 5, 2024Recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:January 9, 2020Completed
Condition(s):Hidradenitis SuppurativaLast Updated:March 6, 2024Recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:February 23, 2024Recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:November 18, 2023Active, not recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:November 14, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.